# GPT 5.2 Review - Reviewer 1/3 (Parallel)

**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** medium
**Timestamp:** 2026-01-29T19:02:59.078666
**Review mode:** Parallel (3 independent reviewers)
**Response ID:** resp_0ae1cd692e4a687400697ba01196808197b5ee7b7e91d28ad8
**Tokens:** 19624 in / 5939 out
**Response SHA256:** d6dffe6dc3c6c970

---

## Referee Report: “Recreational Marijuana Legalization and Business Formation: Evidence from Staggered State Adoption” (January 29, 2026)

### Summary (for the editor)
The paper asks whether opening legal recreational cannabis retail markets affects overall entrepreneurship, measured using Census BFS EIN applications. The author exploits staggered “first retail sales” timing across 21 states (2014–2024) in a state-by-year DiD, reporting (i) TWFE estimates of roughly −7% on applications per capita (marginally significant) and (ii) Callaway–Sant’Anna (CS) estimates around −3% (imprecise). Event studies show no strong evidence of pre-trends and suggest a gradually emerging negative effect. The paper also shows a *descriptive* positive association for BF8Q formations, but correctly notes BF8Q is forward-looking and not causally identified in the DiD framework as implemented.

The topic is relevant and the BFS measure is attractive. However, for a top general-interest outlet, the current version has (a) a weak and fragile headline finding, (b) substantial remaining identification threats at the state-year level (COVID-era confounding; spillovers; policy bundling; treatment intensity mismeasurement; choice of retail-opening timing vs anticipation), (c) underdeveloped economic interpretation and mechanisms, and (d) several design choices that leave power and credibility on the table (annual aggregation despite monthly BFS; limited use of modern “robust-to-violations” DiD inference; limited exploration of heterogeneity/intensity).

---

# 1. FORMAT CHECK

**Length**
- The PDF excerpt shows page numbers up to **34** including appendices (e.g., Figures 5–6 on pp. 32–33). The main text appears to run through about **p. 25–26** before references/appendix. This is **borderline but likely meets** the “25 pages excluding references/appendix” threshold depending on what is counted (references begin around p. 26).

**References**
- The bibliography covers core DiD/staggered-adoption papers (Goodman-Bacon; de Chaisemartin & D’Haultfœuille; Sun & Abraham; Callaway & Sant’Anna; Borusyak et al.) and key BFS/business dynamism citations (Haltiwanger, Decker et al.). Domain references are present but **not fully comprehensive** for cannabis policy economics and for “policy evaluation under imperfect parallel trends” (see Section 4 below for missing items and BibTeX).

**Prose (bullets vs paragraphs)**
- Introduction, Results, Discussion are in paragraph form (good).
- Conceptual Framework contains bullet-like enumerations (acceptable), but some subsections drift toward “report style” listing. This is fixable.

**Section depth**
- Intro has multiple substantive paragraphs; Results and Discussion are multi-paragraph.
- Institutional background is detailed. Data/empirical strategy are reasonably developed.
- Some subsections (e.g., limitations) are list-like; for a top journal, convert key limitations into a tighter narrative and prioritize the most consequential threats.

**Figures**
- Figures shown (1–6) have visible series, axes, labels, and treatment markers (e.g., Fig. 1 on p. 16; Fig. 2 on p. 19). They look legible and interpretable.
- For publication: ensure consistent fonts/sizing and that confidence bands are clearly defined in notes.

**Tables**
- Tables (e.g., Table 3, Table 5 on p. 20) contain real estimates with SEs and N (good). No placeholders observed.

---

# 2. STATISTICAL METHODOLOGY (CRITICAL)

### (a) Standard Errors
**Pass.** Reported tables include SEs in parentheses (e.g., Table 3; Table 5 on p. 20). CS estimates report bootstrap SEs (Table 4).

### (b) Significance Testing
**Pass.** Conventional clustered SE inference is used; additionally randomization inference and pairs cluster bootstrap are provided (Section 6.7; permutation distribution figure on p. 23).

### (c) Confidence Intervals (95%)
**Partial pass.**
- CS overall ATT includes a 95% CI (Table 4 Panel A).
- TWFE results mostly show SEs and stars but not consistently 95% CIs in the main tables. For a top outlet, the main result table should report **95% CIs** (and ideally exact p-values) for the headline estimands.

### (d) Sample Sizes
**Pass.** N reported (e.g., 1,020 for BFS application series; 623 for BF8Q).

### (e) DiD with staggered adoption
**Conditional pass, but needs strengthening.**
- The paper **does not rely solely on TWFE**; it implements **Callaway–Sant’Anna** with never-treated comparisons (good).
- However, the paper still gives prominence to TWFE point estimates (Abstract and Section 6.2), and the CS results are less supportive/precise. In a top-journal framing, the heterogeneity-robust estimator should be treated as primary, and TWFE should be explicitly framed as “legacy benchmark.”

### (f) RDD
Not applicable.

**Bottom line on methodology**: This is **not unpublishable** on inference grounds. The paper clears basic inference requirements and uses modern staggered DiD tools. The main issue is *credibility and interpretability* of the state-level design and the weakness/imprecision of the core effect.

---

# 3. IDENTIFICATION STRATEGY

### Credibility
The identification hinges on parallel trends in state-level business applications absent retail opening. The paper provides event studies (CS dynamic aggregation, Fig. 2 on p. 19) and finds no obvious pre-trends.

However, for a top field/general-interest journal, the current credibility case is not yet strong enough because:

1. **Timing/anticipation and treatment definition**
   - Treatment is the **year** of first retail sales, even though BFS is **monthly** and retail opening is a specific date (Table 1 lists exact dates). Annualizing likely introduces:
     - **Treatment misclassification** within year (partial exposure).
     - Attenuation and muddier dynamics.
     - Potential **anticipation** in the months before opening (licensing, real estate, incorporation, vendor formation).
   - A monthly (or at least quarterly) event study would be substantially more compelling and feasible with BFS.

2. **COVID-era confounding**
   - The paper acknowledges the 2020–2021 application boom and drops those years as a robustness check (Table 6). Good, but not sufficient: later cohorts’ identification is still entangled with pandemic recovery and policy responses that differed across states.
   - The “exclude COVID years” robustness is coarse and may introduce selection on timing (you are dropping post-treatment years for some cohorts more than others).

3. **Spillovers and interference**
   - Cross-border effects (entrepreneurs forming entities across state lines, consumers crossing borders, supply chains) are plausible and likely first-order for cannabis. A state-level DiD with “never-treated” controls assumes no interference. The paper notes spillovers as a limitation (Section 7.3) but does not quantify them.
   - For a top journal, you likely need a design that directly addresses spillovers (e.g., border-county design, distance-to-border gradients, excluding border states, or modeling exposure).

4. **Policy bundling / omitted time-varying confounders**
   - States legalizing recreational cannabis may simultaneously implement other business-relevant changes (tax policy, licensing reforms, minimum wage increases, paid leave, etc.). State FE absorb time-invariant differences; year FE absorb national shocks; but **state-specific time-varying confounders remain**.
   - The paper currently has limited controls (medical marijuana indicator in some specs). This is thin for general-interest credibility.

5. **Parallel trends testing**
   - The paper notes it cannot compute a joint pre-trends test due to singular covariance (Appendix B.1). In top outlets, reviewers will expect either:
     - A feasible joint test (with an adjusted approach), or
     - An “honest DiD” sensitivity analysis showing robustness to small deviations from parallel trends (see Section 4).

### Placebos and robustness
You provide multiple robustness checks (RI, bootstrap, medical-only controls, excluding COVID). That is good. But several *high-value* falsifications are missing:
- **Alternative treatment dates** (legalization passage vs retail opening; licensing start; first dispensary license issuance; first tax revenue receipt).
- **Placebo treatment cohorts** (assign “fake opening years” to treated states in pre-period only).
- **Negative control outcomes** (if any exist in BFS or related series).
- **Border-state spillover tests** (exclude neighbors of treated states; or run models only on interior states).

### Do conclusions follow from evidence?
Mostly yes and commendably cautious on BF8Q (Section 6.5). But the paper sometimes drifts toward interpretive claims (“quality upgrade” hypothesis) without mechanism evidence beyond compositional patterns that are only weakly identified.

---

# 4. LITERATURE (missing references + BibTeX)

### (i) Methods: modern DiD robustness/sensitivity beyond event studies
To meet top-journal norms, you should cite and ideally implement or discuss “robust to violations” approaches:

1) **Rambachan & Roth (2023)** (Honest DiD / sensitivity to pre-trend violations)  
Why: Your pre-trend evidence is central, but joint tests are problematic in your setting; honest DiD is now standard in top outlets.

```bibtex
@article{RambachanRoth2023,
  author  = {Rambachan, Ashesh and Roth, Jonathan},
  title   = {A More Credible Approach to Parallel Trends},
  journal = {Review of Economic Studies},
  year    = {2023},
  volume  = {90},
  number  = {5},
  pages   = {2555--2591}
}
```

2) **Roth (2022)** (pre-trends, power, and interpretation of event studies)  
Why: Your event-study pre-period estimates are “not significant,” but that is not the same as “no differential pre-trends.”

```bibtex
@article{Roth2022,
  author  = {Roth, Jonathan},
  title   = {Pretest with Caution: Event-Study Estimates after Testing for Parallel Trends},
  journal = {American Economic Review: Insights},
  year    = {2022},
  volume  = {4},
  number  = {3},
  pages   = {305--322}
}
```

3) **Arkhangelsky et al. (2021)** (Synthetic DiD)  
Why: Given staggered adoption, small number of treated units per cohort, and concerns about differential trends, synthetic DiD is a natural complement and often persuasive to general-interest audiences.

```bibtex
@article{ArkhangelskyEtAl2021,
  author  = {Arkhangelsky, Dmitry and Athey, Susan and Hirshberg, David A. and Imbens, Guido W. and Wager, Stefan},
  title   = {Synthetic Difference-in-Differences},
  journal = {American Economic Review},
  year    = {2021},
  volume  = {111},
  number  = {12},
  pages   = {4088--4118}
}
```

4) **Xu (2017)** (Generalized Synthetic Control)  
Why: Another standard comparative-case approach for policy evaluation with panel data and heterogeneous trends.

```bibtex
@article{Xu2017,
  author  = {Xu, Yiqing},
  title   = {Generalized Synthetic Control Method: Causal Inference with Interactive Fixed Effects Models},
  journal = {Political Analysis},
  year    = {2017},
  volume  = {25},
  number  = {1},
  pages   = {57--76}
}
```

### (ii) Inference with few clusters / wild bootstrap practice
You cite MacKinnon et al. (2023) and implement pairs bootstrap and RI, which is good. Still, top-journal referees commonly expect **wild cluster bootstrap** p-values/CI as a benchmark.

5) **Roodman et al. (2019)** (“fast and wild” wild cluster bootstrap)  
Why: Practical standard for clustered inference with limited clusters.

```bibtex
@article{RoodmanEtAl2019,
  author  = {Roodman, David and Nielsen, Morten {\O}rregaard and MacKinnon, James G. and Webb, Matthew D.},
  title   = {Fast and Wild: Bootstrap Inference in Stata Using Boottest},
  journal = {The Stata Journal},
  year    = {2019},
  volume  = {19},
  number  = {1},
  pages   = {4--60}
}
```

### (iii) Cannabis policy economics beyond what’s cited
Your domain citations are reasonable but still light for a general-interest positioning. Depending on the channel emphasized, you should consider adding a few canonical empirical references on recreational legalization’s broader effects (labor markets, local economic activity, crime/traffic), especially those using openings/dispensary timing:

(Examples below—choose those closest to your mechanism story; do not pad citations.)

6) **Hansen, Miller & Weber (2020)** (dispensary access / local outcomes; one example of “openings” design)  
If you lean on “retail opening matters,” you want more literature that treats openings as the relevant margin.

```bibtex
@article{HansenMillerWeber2020,
  author  = {Hansen, Benjamin and Miller, Keaton and Weber, Caroline},
  title   = {The Taxation of Recreational Marijuana and the Demand for Legal and Illegal Cannabis},
  journal = {Journal of Public Economics},
  year    = {2020},
  volume  = {191},
  pages   = {104318}
}
```

*(If you use a different Hansen/Miller/Weber paper depending on your actual channel—prices, crime, traffic—swap accordingly. The key is: cite “retail access/openings” work.)*

---

# 5. WRITING QUALITY (CRITICAL)

### (a) Prose vs bullets
- **Mostly passes.** Major sections are paragraphs. Bullets are primarily in Data/Conceptual Framework (acceptable).
- Still, some parts read like a technical report (notably the long lists of channels in Section 3 and threats-to-validity lists in Section 5.6/7.3). For AER/QJE/JPE/ReStud, convert the most important items into a *tighter argument* with prioritization.

### (b) Narrative flow
- The intro is competent and well-motivated, and the “retail opening vs legalization” distinction is a strong organizing idea.
- The narrative stakes are not yet high enough for a top general-interest journal. Right now it reads as “does policy X move BFS applications?” rather than “what does legalization do to business dynamism and why should we care?”

### (c) Sentence quality
- Generally clear, but frequently abstract (“theoretically ambiguous,” “several channels”) without sharp, testable implications.
- Many paragraphs could start with stronger topic sentences and more concrete magnitudes.

### (d) Accessibility
- Econometric choices are reasonably explained. The BF8Q caveat is unusually clear and responsible (a plus).
- You should explain BFS series *more intuitively* (especially HBA/WBA) and why a reader should believe they map to “quality” or “seriousness.”

### (e) Figures/Tables
- Figures appear legible with axes and treatment markers (e.g., Fig. 1 p. 16; Fig. 2 p. 19; coefficient plot Fig. 3 p. 20).
- For publication: ensure every figure note defines units, transformations (logs, per capita), and the meaning of bands (95% CI? pointwise?).

---

# 6. CONSTRUCTIVE SUGGESTIONS (to make the paper top-journal impactful)

## A. Use the data frequency you already have (monthly BFS)
**This is the single highest-return revision.**
- Re-estimate at **monthly** (or quarterly) frequency with treatment at the **month of first retail sale**.
- Show event time in months (−36 to +60, say), then aggregate to yearly bins for readability.
- This reduces measurement error, improves dynamic interpretation, and helps separate anticipation vs post-opening effects.

## B. Address spillovers explicitly
At minimum, implement two of the following:
1. **Border exclusion:** drop states bordering treated states in each year (or drop border counties if you move to sub-state data).
2. **Distance-to-treatment exposure:** construct exposure based on neighboring states’ retail opening (weighted by border length/population).
3. **“Donut” comparison:** compare treated states to a set of “far” controls (no treated neighbors) and show robustness.

Without something like this, “never-treated states” are not a clean counterfactual.

## C. Strengthen the identification story beyond “no significant pre-trends”
- Implement **Honest DiD** (Rambachan–Roth) to show how sensitive your ATT is to plausible deviations from parallel trends.
- Alternatively/additionally, implement **Synthetic DiD** as a complementary estimand. If SDiD and CS point in the same direction, credibility increases substantially.

## D. Reconsider outcome model (logs vs counts; weighting)
- BFS outcomes are **counts** with large cross-state heterogeneity. Consider:
  - Poisson pseudo-ML with state and time FE (PPML), using population as exposure, or
  - at least show robustness to **levels per capita** and **asinh**.
- Decide whether the estimand is “average state effect” (unweighted) or “average person effect” (population-weighted). Report both.

## E. Mechanisms / interpretation: show where the decline comes from
Right now, “applications fall” is hard to interpret.
- If BFS state-by-sector is unavailable, bring in complementary sources:
  - **BDS establishment births** (as Brown et al. do) for formation-year outcomes.
  - **State business registries** (where feasible) or proprietary datasets that classify industries.
  - **Cannabis licensing counts**, dispensary counts, sales/tax revenues as intensity measures.
- Show whether declines are concentrated among:
  - low-propensity applications,
  - specific legal forms,
  - periods of regulatory tightening,
  - states with stricter licensing caps/local bans.

## F. Clarify and tighten the BF8Q discussion
You do the right thing by warning readers (Section 6.5). To reduce confusion:
- Move BF8Q entirely to an appendix, or
- Redefine an estimand aligned with BF8Q’s forward window (e.g., treat “retail opening” as affecting cohorts whose 8-quarter window lies fully post-opening; that implies dropping application cohorts within two years of the opening—costly but conceptually coherent).

## G. Reframe contribution for a general-interest audience
AER/QJE/JPE readers will ask: why does a modest −3% to −7% in applications matter?
- Translate to aggregate counts and compare to secular trends and COVID boom magnitude.
- Connect to business dynamism debate: does legalization reallocate entrepreneurship away from other sectors? Does it raise barriers that screen out marginal entrants? Is it a local amenity affecting migration/consumption?

---

# 7. OVERALL ASSESSMENT

### Key strengths
- Uses a high-quality, nationally consistent entrepreneurship measure (BFS).
- Correctly distinguishes legalization from **retail opening**, a meaningful institutional contribution.
- Employs modern staggered DiD (Callaway–Sant’Anna) and multiple inference procedures (RI, cluster bootstrap).
- Exceptionally clear warning about BF8Q’s forward-looking nature and why that breaks naïve DiD interpretation (many papers get this wrong).

### Critical weaknesses (for top general-interest publication)
- Identification remains **state-level and vulnerable** to spillovers, COVID-era confounding, and policy bundling; robustness is not yet commensurate with these threats.
- Annual aggregation wastes the key advantage of BFS (high frequency) and introduces treatment timing error.
- Main effect is **small and imprecise** under the preferred heterogeneity-robust estimator; results are not consistently statistically distinguishable from zero.
- Mechanisms are largely speculative; composition results are suggestive but not decisive.
- The paper currently reads closer to a careful policy memo than a general-interest journal article with a sharp conceptual payoff.

### Specific, actionable improvements
1) Re-estimate at monthly/quarterly frequency with exact retail-opening dates.  
2) Add spillover-robustness (border exclusions/exposure).  
3) Add Honest DiD (Rambachan–Roth) and/or Synthetic DiD as complementary evidence.  
4) Add intensity/mechanism evidence (licenses, dispensaries, sales/taxes; stricter vs looser regimes).  
5) Tighten framing around business dynamism and reallocation, not just “applications up/down.”

---

DECISION: REJECT AND RESUBMIT